Valuation: Henan Lingrui Pharmaceutical Co., Ltd.

Market Cap 1.25TCr 187.45Cr 167.88Cr 154.43Cr 139.92Cr 261.55Cr 18TCr 266.45Cr 1.84TCr 739.26Cr 9.36TCr 703.49Cr 688.54Cr 30TCr P/E 2026 *
15.1x
P/E 2027 * 14x
Enterprise Value 1.24TCr 185.65Cr 166.27Cr 152.94Cr 138.57Cr 259.03Cr 18TCr 263.88Cr 1.82TCr 732.14Cr 9.27TCr 696.71Cr 681.9Cr 29TCr EV / Sales 2026 *
3.06x
EV / Sales 2027 * 2.8x
Free-Float
75.98%
Yield 2026 *
5.52%
Yield 2027 * 5.74%
1 day+10.00%
1 week+7.21%
Current month+15.91%
1 month+17.71%
3 months-4.89%
6 months-2.48%
Current year+6.23%
1 week 19.68
Extreme 19.68
22
1 month 18.93
Extreme 18.93
22
Current year 18.51
Extreme 18.51
23.65
1 year 18.51
Extreme 18.51
23.65
3 years 15.55
Extreme 15.55
27.26
5 years 10
Extreme 10
27.26
10 years 6.81
Extreme 6.81
27.26
Manager TitleAgeSince
Chief Executive Officer 42 06/06/2014
Director of Finance/CFO 57 06/06/2020
Corporate Officer/Principal 54 08/06/2011
Director TitleAgeSince
Director/Board Member 57 -
Chairman 42 29/04/2019
Director/Board Member 37 06/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
10/01/25 Buy 1,50,000 0.0265%
10/01/25 Buy 1,50,000 0.0265%
10/01/25 Buy

Director

1,50,000 0.0265%
Change 5-day change 1-year change 3-year change Capi.($)
+10.00%+7.21%-4.47%+30.72% 170.19Cr
+3.19%+11.31%+67.86%+150.58% 1,22400Cr
-0.73%+3.56%+44.51%+85.81% 66TCr
+1.41%+3.24%+29.22%+107.83% 51TCr
+0.42%+2.88%+54.92%+69.67% 39TCr
+2.18%+2.93%+73.30%+45.62% 36TCr
+1.12%+3.80%+35.82%+59.72% 30TCr
+6.96%+7.55%+11.15%+37.89% 27TCr
+1.15%+6.09%+59.59%+77.06% 25TCr
+3.06%+9.38%+44.11%+119.47% 21TCr
Average +2.75%+3.01%+41.60%+78.44% 41.79TCr
Weighted average by Cap. +1.62%+3.04%+50.99%+98.63%

Financials

2026 *2027 *
Net sales 403.43Cr 61Cr 54Cr 50Cr 45Cr 85Cr 5.76TCr 86Cr 595.47Cr 239.04Cr 3.03TCr 227.48Cr 222.64Cr 9.55TCr 436.2Cr 66Cr 59Cr 54Cr 49Cr 91Cr 6.22TCr 93Cr 643.83Cr 258.46Cr 3.27TCr 245.95Cr 240.72Cr 10TCr
Net income 83Cr 12Cr 11Cr 10Cr 9.3Cr 17Cr 1.18TCr 18Cr 122.41Cr 49Cr 622.32Cr 47Cr 46Cr 1.96TCr 89Cr 13Cr 12Cr 11Cr 10Cr 19Cr 1.28TCr 19Cr 131.93Cr 53Cr 670.75Cr 50Cr 49Cr 2.12TCr
Net Debt -12Cr -1.81Cr -1.62Cr -1.49Cr -1.35Cr -2.52Cr -171.55Cr -2.57Cr -18Cr -7.13Cr -90Cr -6.78Cr -6.64Cr -284.59Cr -27Cr -4Cr -3.58Cr -3.29Cr -2.98Cr -5.58Cr -379.61Cr -5.68Cr -39Cr -16Cr -199.68Cr -15Cr -15Cr -629.73Cr
Projected Income Statement - Annual - Henan Lingrui Pharmaceutical Co., Ltd.
Logo Henan Lingrui Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical and Health Care segment is mainly engaged in the production and sales of plasters, oral medicines and ointments. The Other segment is mainly engaged in hotel, catering services and others. The Company's main products include Tongluo Qutong Cream, Huoxue Xiaotong Tincture, Zhuanggu Shexiang Pain Relief Cream, Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules and others. The Company mainly operates its businesses in the domestic market.
Employees
2,789
Date Price Change Volume
30/26/30 CN¥22.00 +10.00% 2,02,19,640
29/26/29 CN¥20.00 +0.05% 81,74,000
28/26/28 CN¥19.99 -1.53% 65,51,600
27/26/27 CN¥20.30 -1.46% 71,04,200
26/26/26 CN¥20.60 +1.38% 70,15,550
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Henan Lingrui Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
22.00CNY
Average target price
26.20CNY
Spread / Average Target
+19.09%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Henan Lingrui Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 600285 Stock